Skip to content

Cns Interchangeable Bit Cranial Drill

by Clinical Neuro Systems, LLC

510(k) K961113

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

21 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK961113 Date5 Jun 1996ClearedStatusActive

Recalls

39 recalls · 21 ongoing · FDA

    • Ongoing Z-1873-2024 FDA Class II initiated 17 Apr 2024

    Potential holes and tears in the sterile packaging (header bag) of the Cranial Access Kit may compromise the sterility of the device.

  • 11 recalls, same reason

    • Ongoing Z-1198-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1203-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1201-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1193-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1200-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1195-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1199-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1202-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1196-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1197-2024 FDA Class II initiated 19 Jan 2024
    • Ongoing Z-1194-2024 FDA Class II initiated 19 Jan 2024

    A defect in the sterile packaging (header bag) of the Cranial Access Kit failing the required packaging integrity testing criteria. Therefore, product sterility maybe compromised.

  • 2 recalls, same reason

    • Ongoing Z-0491-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0492-2024 FDA Class II initiated 19 Oct 2023

    Defect in the outer packaging of the Cranial Access Kits can cause the packaging to split without any additional forces outside compromising the sterility of the device

  • 7 recalls, same reason

    • Ongoing Z-0497-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0496-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0499-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0498-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0495-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0494-2024 FDA Class II initiated 19 Oct 2023
    • Ongoing Z-0493-2024 FDA Class II initiated 19 Oct 2023

    Defect in the outer packaging of the Cranial Access Kits. can cause the packaging to split without any additional forces outside compromising the sterility of the device

    • Terminated Z-2733-2016 FDA Class II initiated 24 Aug 2016

    Integra LifeSciences has been notified of a medical device recall by Adaptive Surgical, LLC involving their Riverlon" Nylon 3-0 Sutures that are packaged in Integras Cranial Access Kits. It was found that product seals may become open during extreme distribution conditions and render the device unsterile.

    • Terminated Z-2260-2013 FDA Class II initiated 4 Sep 2013 on shared 510(k) K961113

    Integra is recalling certain lots of Cranial Access Kit due to a possibility that the seal integrity of the sterile package may become compromised during shipping.

  • 12 recalls, same reason

    • Terminated Z-0751-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0750-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0748-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0759-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0755-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0752-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0756-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0757-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0753-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0758-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0754-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011
    • Terminated Z-0749-2012 FDA Unclassified (pre-2012) initiated 21 Dec 2011

    Current package insert was revised to include additional warning information related to the potential hazards of an unapproved off-label use of Xylocaine.

    • Terminated Z-2194-2011 FDA Unclassified (pre-2012) initiated 22 Feb 2011

    Outer packaging of Combo Kit was mislabeled with an incorrect lot number.

    • Terminated Z-2171-2011 FDA Unclassified (pre-2012) initiated 22 Feb 2011

    Outer box of Monitoring Kit was mislabeled with the incorrect part number.

    • Terminated Z-2084-2009 FDA Unclassified (pre-2012) initiated 13 Jul 2009

    Lack of packaging seal integrity on various pain management kits may compromise sterility of contents.

    • Terminated Z-1097-04 FDA Unclassified (pre-2012) initiated 19 Mar 2003 on shared 510(k) K961113

    The outer labeling of the convenience kit indicates that an additional bottle of Sodium Chloride (saline) solution is included in the Custom Kit 31176; however, an additional bottle of 1% Xylocaine was included in the Custom Kit.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
HBG
Device Class
Class II
Regulation
21 CFR Part 882.4300
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Other devices from Clinical Neuro Systems, LLC